These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17877919)

  • 1. The role of hypertriglyceridemia in atherosclerosis.
    Le NA; Walter MF
    Curr Atheroscler Rep; 2007 Aug; 9(2):110-5. PubMed ID: 17877919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical science relating atherosclerotic diseases and hypertriglyceridemia].
    Fujioka Y
    Nihon Rinsho; 2013 Sep; 71(9):1546-51. PubMed ID: 24205712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects.
    Hodis HN; Mack WJ; Krauss RM; Alaupovic P
    Clin Cardiol; 1999 Jun; 22(6 Suppl):II15-20. PubMed ID: 10376192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
    Sandesara PB; Virani SS; Fazio S; Shapiro MD
    Endocr Rev; 2019 Apr; 40(2):537-557. PubMed ID: 30312399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
    Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
    Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
    Malloy MJ; Kane JP
    Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertriglyceridemia and atherosclerosis.
    Peng J; Luo F; Ruan G; Peng R; Li X
    Lipids Health Dis; 2017 Dec; 16(1):233. PubMed ID: 29212549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects.
    Gianturco SH; Bradley WA
    Clin Cardiol; 1999 Jun; 22(6 Suppl):II7-14. PubMed ID: 10376191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
    Grundy SM; Vega GL
    Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.
    Ferguson EE
    Dis Mon; 2000 Jul; 46(7):421-503. PubMed ID: 10943222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statin therapy for atherogenic hypertriglyceridemia].
    Koba S
    Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications.
    Akivis Y; Alkaissi H; McFarlane SI; Bukharovich I
    Curr Cardiol Rev; 2024; 20(2):39-49. PubMed ID: 38288833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia: a review beyond low-density lipoprotein.
    Rapp RJ
    Cardiol Rev; 2002; 10(3):163-72. PubMed ID: 12047794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglyceride connection in atherosclerosis.
    Geurian K; Pinson JB; Weart CW
    Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism.
    Ginsberg HN
    Circulation; 2002 Oct; 106(16):2137-42. PubMed ID: 12379586
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
    Dergunov AD
    Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction.
    Tsunoda F; Koba S; Hirano T; Ban Y; Iso Y; Suzuki H; Geshi E; Katagiri T
    Circ J; 2004 Dec; 68(12):1165-72. PubMed ID: 15564701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.